A biomarker panel that simultaneously measures the expression of 57 synovial tissue proteins could be used to predict which patients with psoriatic arthritis (PsA) would respond to tumor necrosis factor (TNF) α inhibitors or T-cell inhibitors, researchers report in an article published online September 3 in the Annals of the Rheumatic Diseases.

Click Here to read more